Emerging Infectious Disease Tests and Companies Developing New Technologies and Products

Sep 13, 2011, 04:01 ET from Reportlinker

NEW YORK, Sept. 13, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Emerging Infectious Disease Tests and Companies Developing New Technologies and Products

http://www.reportlinker.com/p0368558/Emerging-Infectious-Disease-Tests-and-Companies-Developing-New-Technologies-and-Products.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

The report provides a comprehensive marketing and technological assessment, as well as medical rationale and diagnostic prospects for nearly 80 infectious diseases and viruses, including their scientific background, clinical significance and market needs for both current and emerging tests, vaccines, drugs and extensive listings of companies developing or marketing new technologies and products.

Contains 650 pages and 47 tables

Table of Contents

1. AIDS

a. Background

Structure and Composition

Classification

Origin of AIDS

Animal Lentivirus Systems

Virus Receptos

HIV Infections in Humans

Pathogenesis & Pathology: Overview of

HIV Infection Course

CD4T Lymphocytes and Memory Cells

Monocytes and Macrophages

Lymphoid Organs

Neural Cells

Viral Coinfections

Clinical Findings

Plasma Viral Load

Pediatric AIDS

Neurologic Disease

Opportunistic Infections

Cancer

Immunity

Virus Isolation

Serology

Detection of Viral Nucleic

Acid and Antigens

Infectivity

Epidemiology

Worldwide Spread of AIDS

United States

Routes of Transmission

b. Diagnostic Tests

Laboratory Diagnosis

Enzyme Immunoassay Interpretation

Specific, Sensitivity, and Predictive

Value of Enzyme Immunoassays

Competition Assays

Western Blot Technique

Immuno-Fluorescence Assay (IFA)

Radioimmunoprecipitation

HIV-1/HIV-2 Combination Testing

Methods of HIV-Antigen Detection

Antigen Assays and Blood Screening

Urine Tests

Immunopathogenic Mechanism of HIV Infection

DNA Probes

Overview

Quantitative Polymerase Chain Reaction

In Situ PCR

Needed Improvements

Viral Load/Drug Resistance Testing

Genotype and Phenotype Testing

Blood Banking Consideration

c. Vaccines and Drugs

Antiviral Drugs

Vaccines Against HIV

Transmission of HIV in Blood Products

HIV Transmission in Transplant and

Artificial Insemination Recipients

2. Adenovirus

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

d. Adeno-Associated Viruses(AAV)

3. Aeromonas

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

4. Anthrax/Bacillus Anthracis

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

5. Arboviruses

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

6. Babesiosis

a. Background

7. Bacillary Epithelioid Angiomatosis (BEA)

And Other Bartonella (Rochalimaea)

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

8. Blastocystis Hominis

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

9. Brucella

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

10. Campylobacter

a. Background

b. Diagnostic Tests

Identification from Culture

c. Vaccines and Drugs

11. Candida

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

12. Chagas Disease

a. Background

13. Chancroid

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

14. Chlamydia

a. Background

Chlamydia Psittaci

Chlamydia Pneumoniae

Chlamydia Trachomatis

b. Diagnostic Tests

c. Vaccines and Drugs

15. Clostridium Difficile

a. Background

Pediatric Infections

Epidemiology

b. Diagnostic Tests

Counterimmunoelectrophoresis

Fluorescent-Antibody Assays

Poloymerase Chain Reactions

c. Drugs and Vaccines

16. Coronaviruses

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

17. Coxsackieviruses

a. Background

Herpangina

Hand-foot-and-mouth syndrome

Hepidemic Conjuctivitis

Pharingitis

Epidemic Pleurodynia

Myodarditis,Pericarditis

Overwhelming Infection of the Newborn

Acute Aseptic Meningitis

Undifferentiated Febrile Illness

Fever with upper respiratory infection

Encephalitis

Asymptomatic Infection

b. Diagnostic Tests

c. Vaccines and Drugs

18. Creutzfeldt-Jakob's Disease

a. Background

Blood Transmission

b. Diagnostic Tests

Major Commercial and Academic Players

Bayer

Disease Sciences/Bio Tec Global

Imperial College of Medicine

Ortho-Clinical Diagnostics

Pall

ProMetic Life Sciences

Proteome Sciences/Idexx

Q-One Biotech

Serono

U.S. Agricultural Research Service

c. Vaccines

19. Cryptosporidium Parvum

a. Background

b. Diagnostic Tests

Histologic

Laboratory Parasitology

Serodiagnosis

c. Vaccines and Drugs

20. Cyclospora Cayetanensis

a. Background

Asymptomatic Infection

Diarrhea in Immunocompetent Persons

Diarrhea in Immunocompromisedersons

b. Diagnostic Tests

c. Vaccines and Drugs

21. Cytomegalovirus

a. Background

Chorioretinitis

Gastrointestinal

Central Nervous System Disease

b. Diagnostic Tests

c. Vaccines and Drugs

22. Ebola Virus

a. Background

Epidemiology

Hemorrhagic Fever

b. Diagnostic Tests

c. Vaccines and Drugs

23. E. Coli

a. Background

Role of Escherichia Coli in

Causing Diarrhea

EPEC

ETEC

EIEC

EHEC

b. Diagnostic Tests

c. Vaccines and Drugs

24. EchoVirus

a. Background

Acute Aseptic Miningitisis

Encephalitis

Exanthems

Respiratory Disease

Myope;ricarditis

Neonatal Infections

b. Diagnostic Tests

c. Vaccines and Drugs

25. Encephalitis

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

26. Enteroviruses

a. Background

b. Diagnostic Tests

Viral Isolation and Identification

Antibody Tests

c. Vaccines and Drugs

27. Epstein-Barr Virus

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

28. Giardia Lamblia

a. Background

Life Cycle and Morphology

Morphology of Trophozoites

Clinical Disease

b. Diagnostic Tests

c. Vaccines and Drugs

29. Gonorrhea

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

30. Granuloma Inguinale

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

31. Hantavirus

a. Background

Identification of the Agent

Transmission

Other Rodent Hantaviruses

Distribution

Hantavirus Diseases

Epidemiology

Addendum in Proof-Northeastern Connection

Previously Unknown Pathogens

Cases Nationwide

b. Diagnostic Tests

An Immunohistochemistry Approach

Hantavirus Rapid Diagnostic Test

ELISA Diagnosis of Hantavirus Pulmonary

Syndrome

IgG ELISA

IgM Capture ELISA

c. Vaccines and Drugs

32. Helicobacter Pylori

a. Background

Pathogenesis

Role in Peptic Ulcer Disease

Role in Gastric Cancer

Nonulcer Dyspepsia

b. Diagnostic Tests

c. Vaccines and Drugs

Specific Therapeutic Regimens

Who Should Be Treated?

Participants in Controlled Clinical Trials

Patients with Refractory Peptic Ulcer

Patients with Refractory NUD

Patients in High-Risk Groups for Gastric

Cancer

33. Hepatitis

a. Background

b. Hepatitis A

c. Hepatitis B

d. Hepatitis C

Classification

Transmission of Infection

Occupational Hazards

Acute Hepatitis

Diagnosis of Acute Infection

Chronic Hepatitis

HCV and Other Chronic Liver Diseases

Alcoholic Liver Disease

Hepatitis B Coinfection

Cirrhosis and Hepatocellular Carcinoma

Diagnostic Tests

Possible Indications for HCV RNA Testing

Conclusions and Future Direction

e. Hepatitis D

Historical Perspective

Epidemiology

HBV-HDV "Coinfection" vs. "Superinfection"

Methods of Detecting HDV

Prevention

f. Hepatitis E

Background

Prevalence of the Disease

Diagnostic Tests

Epidemiologic Serosurveys

Serologic Cross-Reactivity

g. Hepatitis G

Vaccines and Drugs

34. Herpes Simplex Virus

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

35. Human Herpes Virus-6 (HHV-6)

a. Background

HIV-6 Infections

b. Diagnostic Tests

c. Vaccines and Drugs

36. Influenza Viruses

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

37. Legionella

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

38. Lyme Disease

a. Background

Clinical Description

Clinical Case Definition

Laboratory Criteria for Diagnosis

Case Classification

b. Diagnostic Tests

c. Vaccines and Drugs

39. Lymphogranuloma Venereum (LGV)

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

40. Malaria

a. Background

b. Diagnostic Tests

Potential Diagnositic Problems with Positive

Patients from Non-endemic Areas

Patient

Laboratory

Physician

c. Vaccines and Drugs

41. Measles (Rubeola)

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

42. Meningitis

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

Development of Polysaccharide Vaccines

Quadrivalent Vaccine Development

Meningococcal A.C.Y. & W-135 Vaccines

Efficacy of Group C Vaccine

Efficacy of Group A Vaccine

Combinations of Group A and C Vaccines

Group B Efficacy Trials

Future Direction

43. Microsporidium

a. Background

Prevalence and Geographic Distribution

Sources of Human Infection and Transmission

b. Diagnostic Tests

Light Microscopic Examination of Stool

Specimens By Chromotrope Staining

Stool Concentration Methods

Chemofluorescent Agents

Giemsa Staining of Stool Specimens

Cytologic Diagnosis

Histologic Examination

Electron Microscopy

Examination of Bodily Fluids

Examination of Tissue Sections

Immunofluorescence Detection Procedures

Serology

Cell Culture

Approach to Diagnosis

Evaluation of Patients with Presumptive

Intestinal Microsporidiosis

Evaluation of Patients with Presumptive

Ocular Microsporidiosis

c. Vaccines and Drugs

44. Mononucleosis

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

45. Mumps

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

Efficacy of Vaccination

Future Issues

46. Mycoplasma

a. Background

Ureaplasma Urealyticum & Mycoplasma Hominis

b. Diagnostic Tests

c. Vaccines and Drugs

47. Papillomaviruses

a. Background

HPV in Cancer

Cervical Neoplasm

b. Diagnostic Tests

c. Vaccines and Drugs

Prevention

48. Parvovirus B19

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

49. Pneumonia

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

50. Polyomaviruses

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

51. Pseudomonas Aeruginosa

a. Background

Virulence Factors

b. Diagnostic Tests

c. Vaccines and Drugs

52. Rabies

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

53. Respiratory Syncytial Virus (RSV)

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

54. RhinoViruses

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

55. RotaVirus (REOVIRUS)

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

56. Rubella(MEASLES)

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

Developing Countries

Elimination and Eradication of Measles

New Developments

57. Salmonellosis

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

58. Septicemia

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

59. Shigellosis

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

60. Staphylococcus Aureus

a. Background

The Genus Taphylococcus

b. Diagnostic Tests

c. Vaccines and Drugs

Prevention

61. Streptococci

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

Group A Streptococci

Group B Streptococci

62. Syphilis

a. Background

b. Diagnostic Tests

Biopsy

Rabbit Infectivity Testing

Other Diagnostic Modalities

c. Vaccines and Drugs

Syphilis and HIV Infection

Syphilis As a Cofactor for HIV Transmission

Basic Science Issues

63. Toxoplasmosis

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

64. Trichomonas Vaginalis

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

65. Tuberculosis

a. Background

b. Diagnostic Tests

Microscopic Characteristics

Cultural Characteristics

Detection of Antibodies

Skin Tests

MDRTB

c. Vaccines and Drugs

66. Vibrio

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

67. West Nile Virus

a. Background

Clinical Syndromes

b. Diagnostic Tests

c. Vaccines and Drugs

68. Yersina

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

List of Tables

Major Companies Developing or Marketing AIDS Tests

Major Companies Developing or Marketing Adenovirus Tests

Major Companies Developing or Marketing Bartonella Tests

Major Companies Developing or Marketing

Campylobacter Tests

Major Companies Developing or Marketing Candida Tests

Major Companies Developing or Marketing Chlamydia Tests

Major Companies Developing or Marketing Clostridium Tests

Major Companies Developing or Marketing Coronavirus Tests

Major Companies Developing or Marketing Cryptosporidium Tests

Major Companies Developing or Marketing CMV Tests

Major Companies Developing or Marketing Echovirus Tests

Major Companies Developing or Marketing Enterovirus Tests

Major Companies Developing or Marketing EBV Tests

Major Companies Developing or Marketing Giardia Tests

Major Companies Developing or Marketing Gonorrhea Tests

Major Companies Developing or Marketing Hantavirus Tests

Major Companies Developing or Marketing Helicobacter Pylori Tests

Major Companies Developing or Marketing Hepatitis Tests

Major Companies Developing or Marketing Herpes Tests

Major Companies Developing or Marketing Influenza Tests

Major Companies Developing or Marketing Legionella Tests

Major Companies Developing or Marketing Lyme Disease Tests

Major Companies Developing or Marketing Lymphogranuloma Tests

Major Companies Developing or Marketing Malaria Tests

Major Companies Developing or Marketing Measles Tests

Major Companies Developing or Marketing Meningitis Tests

Major Companies Developing or Marketing Microsporidium Tests

Major Companies Developing or Marketing Mononucleosis Tests

Major Companies Developing or Marketing Mumps Tests

Major Companies Developing or Marketing Mycoplasma Tests

Major Companies Developing or Marketing Papilloma Virus Tests

Major Companies Developing or Marketing Parvovirus Tests

Major Companies Developing or Marketing Pneumonia Tests

Major Companies Developing or Marketing RSV Tests

Major Companies Developing or Marketing Rotavirus Tests

Major Companies Developing or Marketing Rubella Tests

Major Companies Developing or Marketing Salmonella Tests

Major Companies Developing or Marketing Septicemia Tests

Major Companies Developing or Marketing Shigella Tests

Major Companies Developing or Marketing Staphylococci Tests

Major Companies Developing or Marketing Streptococci Tests

Major Companies Developing or Marketing Syphilis Tests

Major Companies Developing or Marketing Toxoplasmosis Tests

Major Companies Developing or Marketing Trichomonas Tests

Major Companies Developing or Marketing Tuberculosis Tests

Major Companies Developing or Marketing West Nile Tests

Major Companies Developing or Marketing Yersinia Tests

To order this report:

In Vitro Diagnostic Industry: Emerging Infectious Disease Tests and Companies Developing New Technologies and Products

In Vitro Diagnostic Business News

More  Market Research Report

Check our  Industry Analysis and Insights

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker



RELATED LINKS

http://www.reportlinker.com